Can Can-Fite’s Piclidenoson Put Up A Fight In Psoriasis?

Can-Fite announced topline results from the Phase III COMFORT trial of piclidenoson • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immunological

More from Therapy Areas